Literature DB >> 8572543

Intraoral salivary duct carcinoma: a clinicopathological study of four cases and review of the literature.

A Epivatianos1, J Dimitrakopoulos, G Trigonidis.   

Abstract

Salivary duct carcinoma (SDC) is a distinctive entity of highly malignant salivary gland tumors. We present the clinical features and outcomes of four cases in minor salivary glands and of 69 additional cases previously reported in the literature. The tumor occurs most frequently in the sixth and seventh decades of life with a 3.8:1 male preponderance. The prognosis is dismal. Sixty-one percent of patients were dead within 5 months to 10 years (mean 25 months) and the rate of lymph node metastasis was 60%. Twenty-eight percent of patients were without evidence of the disease for 13 months to 9 years (mean 33 months). The histologic features, differential diagnosis, and origin of SDC are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 8572543

Source DB:  PubMed          Journal:  Ann Dent        ISSN: 0003-4770


  4 in total

Review 1.  [Salivary duct carcinoma].

Authors:  D Hungermann; K Roeser; H Buerger; T Jäkel; T Löning; H Herbst
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

2.  Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Vijayvel Jayaprakash; Mihai Merzianu; Graham W Warren; Hassan Arshad; Wesley L Hicks; Nestor R Rigual; Maureen A Sullivan; Mukund Seshadri; James R Marshall; David M Cohan; Yujie Zhao; Anurag K Singh
Journal:  Head Neck       Date:  2013-10-07       Impact factor: 3.147

3.  Intra-oral minor salivary duct carcinoma.

Authors:  Rajeev Sen; Prashant Purwar; Bharat Rekhi; Sunita Singh; B Arora; Jyotsna Sen; O P Sachdeva
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-04

4.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.

Authors:  Takeshi Imai; Kensuke Shinohara; Kenji Uchino; Hirohisa Okuma; Futaba Maki; Kiyoshi Hiruma; Yasushi Ariizumi; Yoshihisa Yamano
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.